Results 61 to 70 of about 575 (111)

NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression. [PDF]

open access: yesJ Immunol
Giridharan T   +20 more
europepmc   +1 more source

BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis. [PDF]

open access: yesJCO Precis Oncol
Hahnen E   +37 more
europepmc   +1 more source

Perinatal Outcomes and Level of Labour Difficulty in Deliveries with Right and Left Foetal Position-A Preliminary Study. [PDF]

open access: yesHealthcare (Basel)
Witkiewicz M   +10 more
europepmc   +1 more source

Three-Layered Composite Scintillator Based on the Epitaxial Structures of YAG and LuAG Garnets Doped with Ce3+ and Sc3+ Impurities. [PDF]

open access: yesMaterials (Basel)
Witkiewicz-Łukaszek S   +11 more
europepmc   +1 more source

Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle. [PDF]

open access: yesNat Commun
Kumarasamy V   +15 more
europepmc   +1 more source

Investigation of X-rays Beams Uniformity in Radiotherapeutic Tumor Treatment Procedure Using LuAG:Ce Crystal Detectors. [PDF]

open access: yesMaterials (Basel)
Witkiewicz-Łukaszek S   +5 more
europepmc   +1 more source

Real-World Experience among Elderly Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitor-Based Therapy. [PDF]

open access: yesCancers (Basel)
O'Connor TN   +6 more
europepmc   +1 more source

Cu(ii) binding to an antimicrobial shrimp peptide - a small step for structural chemistry, a big leap for medicinal applications. [PDF]

open access: yesChem Sci
Miller A   +9 more
europepmc   +1 more source

Acquired resistance in cancer: towards targeted therapeutic strategies. [PDF]

open access: yesNat Rev Cancer
Soragni A   +23 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy